Patient-reported outcomes (PROs) of cemiplimab vs chemotherapy in advanced non-small cell lung cancer (aNSCLC): EMPOWER-Lung 1 histology subgroups

Creative Commons License

Sezer A., Kilickap S., GÜMÜŞ M., Bondarenko I., ÖZGÜROĞLU M., Gogishvili M., ...More

ANNALS OF ONCOLOGY, vol.33, no.7, 2022 (SCI-Expanded)

  • Publication Type: Article / Abstract
  • Volume: 33 Issue: 7
  • Publication Date: 2022
  • Doi Number: 10.1016/j.annonc.2022.07.1306
  • Journal Name: ANNALS OF ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University Affiliated: No